Sequence-based modeling of Abeta42 soluble oligomers

Alzheimer's disease is associated with the accumulation of amyloid-beta (Abeta) fibrils, which form a cross-beta structure. These structures are believed to contain parallel beta-sheets and a salt bridge between specific residues. While fibrils are a key pathological feature, recent evidence suggests that soluble oligomers of Abeta may be more directly neurotoxic. Previous studies have explored the structural properties of Abeta fibrils, but the structures of intermediate soluble forms remain less understood. This gap motivated researchers to investigate the possible conformations of soluble Abeta oligomers. Understanding these structures could provide insights into the mechanisms of neurotoxicity. Prior research has shown that Abeta peptides can adopt various conformations depending on environmental conditions. However, the exact structural details of soluble oligomers are still unclear. This uncertainty drives the need for computational modeling to propose potential structures. Such models may help explain how these oligomers contribute to disease progression.

This study aims to model possible conformations of soluble Abeta42 oligomers using sequence-based approaches. The researchers sought to identify stable structures that could form within oligomeric assemblies. They focused on the C-terminal region of Abeta42, which contains a conserved salt bridge between Asp23 and Lys28. This region is structurally similar in both soluble and fibrillar forms of Abeta. The authors propose that sequence similarities with other proteins could inform structural modeling. They selected three proteins—adhesin, Semliki Forest virus capsid protein, and transthyretin—for comparison. These proteins share structural motifs with Abeta42, suggesting potential local similarities. The study's goal is to explore how these similarities might influence oligomer formation.

The researchers used sequence-based modeling to predict the structures of soluble Abeta42 oligomers. They compared the Abeta42 sequence to fragments of three proteins known to have structural similarities. These comparisons were used to infer local structural features. The models focused on the C-terminal region, which contains the Asp23-Lys28 salt bridge. This region was assumed to be structurally conserved across different Abeta forms. The team generated three monomeric models based on these sequence similarities. These models were then extended to form dimers, trimers, tetramers, and hexamers. The resulting structures were analyzed for consistency with existing experimental and theoretical data.

The study produced three monomeric models of Abeta42 that share a conserved C-terminal structure. Each model contains two beta-strands connected by a loop, with the Asp23-Lys28 salt bridge intact. These structures are consistent with those observed in Abeta fibrils. Differences between the models occur in the N-terminal region and the C-terminal tail. The researchers modeled these monomers as part of oligomeric assemblies, including dimers, trimers, tetramers, and hexamers. These assemblies suggest possible stable conformers of soluble Abeta within oligomeric forms. The models were validated against available experimental and theoretical data. The results indicate that these structures could represent some of the most stable conformations of soluble Abeta.

The authors propose that the three monomeric models represent plausible conformations of soluble Abeta42 oligomers. These models are based on sequence similarities with three other proteins. The conserved C-terminal structure supports the presence of the Asp23-Lys28 salt bridge. The researchers suggest that these models could sample some of the most stable conformers of Abeta within oligomeric assemblies. The models were tested against experimental and theoretical data to assess their consistency. The study does not claim that these models are definitive or the only possible structures. Instead, they are presented as potential candidates for further investigation. The authors emphasize the need for additional experimental validation to confirm these findings.